{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504

May 9, 2025SILICON VALLEY, CA - May 9, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced that the Japan Patent Office has granted a new patent protection for its Major Depressive Disorder (MDD) candidate, ABV-1504.


TNL Mediagene Reports 35% Revenue Growth In 2024 Fueled By Business Insider Japan And Gizmodo Japan, Targets Growth Through Acquisitions

May 9, 2025By Meg Flippin Benzinga DETROIT, MICHIGAN - May 9, 2025 (NEWMEDIAWIRE) - From breaking news to cutting-edge advances in technology, TNL Mediagene (NASDAQ: TNMG) is keeping Asian Millennials and Gen Z informed, on-trend and on-topic – and helping advertisers pitch the right products to them.   The next-gen media and data analytics company focused on Millennial and Gen Z audiences in Japan and Taiwan leverages its AI-powered data to create relevant online publications and offer its client base of over 850 regional and global advertisers an effective way to reach this large audience.


The Chlorine Institute Delivers Life-Saving Training at the Mississippi State Fire Academy

May 8, 2025 JACKSON, MS - May 8, 2025 (NEWMEDIAWIRE) - The Chlorine Institute (CI) returned to the Mississippi State Fire Academy last week for its annual CHLOREP Team Training, equipping first responders and hazmat professionals from around the globe with the knowledge and skills needed to respond swiftly and safely to chlorine-related emergencies. CHLOREP - The Chlorine Emergency Plan - is a mutual aid program established by CI to ensure rapid, expert support during chlorine incidents across the U.


TIME names Nancy Brown to list of the most influential people in global health

May 8, 2025(NewMediaWire) - May 08, 2025 - DALLAS — Nancy Brown, Chief Executive Officer of the American Heart Association, has been named to TIME’s 2025 TIME100 Health, a list recognizing the 100 most influential individuals in health. The full list and related tributes appear in the May 26, 2025 issue of TIME, available on newsstands on Friday, May 16, and now at time.


GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025

May 8, 2025GEO-CM04S1 Demonstrates Robust COVID-19 and Mpox Immunogenicity in Immunocompromised Patients and Healthy Adults ATLANTA, GA - May 8, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against infectious diseases and solid tumor cancers, today recapped the presentation of clinical and translational data for its next-generation multi-antigen COVID-19 vaccine candidate, GEO-CM04S1, delivered at IMMUNOLOGY2025™, the Annual Meeting of the American Association of Immunologists (AAI), held May 3–7, 2025, in Honolulu, Hawaii.


AppSwarm Launches AskOptima.com to Advance AI-Powered Search Technology

May 7, 2025TULSA, OKLAHOMA - May 7, 2025 (NEWMEDIAWIRE) - AppSwarm, Corp. (OTC: SWRM), a collective of creative and technological minds focused on gaming app development, business app development, web development, and white-label technology solutions, is proud to announce its launch of AskOptima.


GeoVax Expands Gedeptin® Patent Portfolio

May 7, 2025Allowed Patent Claims Cover the Synergistic Combination of Gedeptin® Therapy with Radiation As a Targeted Approach for Solid Tumors ATLANTA, GA - May 7, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against solid tumors and infectious diseases, announced today that the U.


Forian Inc. to Announce First Quarter 2025 Results on May 14, 2025

May 6, 2025NEWTOWN, PA - May 6, 2025 (NEWMEDIAWIRE) - Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, will announce its first quarter 2025 financial results on Wednesday, May 14, 2025, after the close of the market.


GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production

May 6, 2025Company’s Advanced Manufacturing Proposal Supports National Biosecurity Goals and Executive Action on Domestic Pharmaceutical Supply Chains ATLANTA, GA - May 6, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against infectious diseases and solid tumors, today voiced strong support for the Executive Order signed by President Trump on May 5, 2025, aimed at restoring a robust U.


More women with most common autoimmune diseases die from cardiovascular disease than men

May 6, 2025Research Highlights: In a study focused on individuals with the immune-mediated inflammatory diseases rheumatoid arthritis, lupus or systemic sclerosis, the overall cardiovascular disease-related death decreased for all participants between 1999 and 2020. However, women had a 50% higher cardiovascular disease-related death rate than men.


7-HOPE Alliance Launches to Support Science-Backed Advocacy for 7-OHM Consumers Amidst Misinformation Campaigns

May 6, 2025New Nonprofit Launches to Engage in Science, Advocacy, and Support of Users of 7-hydroxymitragynine (7-OHM) Based Products LOS ANGELES, CA - May 6, 2025 (NEWMEDIAWIRE) - Today marks the official launch of 7-HOPE Alliance, (“7-HOPE”) a trailblazing nonprofit coalition dedicated to protecting legal access to 7-hydroxymitragynine (7-OHM), a kratom-based alkaloid that is positively transforming lives across the country. As misinformation and a concentrated campaign to ban this emerging natural product ingredient is taking place in multiple states across the U.